Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 November 2020 | Story Dr Nitha Ramnath

In this webinar, Prof Brownhilder Neneh of the University of the Free State, and Christopher Rothmann, co-founder of LiquidCulture, discuss the intersection between the two fields of science and entrepreneurship, and entrepreneurship and the university curriculum from an interdisciplinary perspective. The webinar will provide insight into entrepreneurship at universities, particularly the UFS, advancing entrepreneurship development and entrepreneurship-related programmes that are student focused, and illustrate the critical role that entrepreneurship plays in the lives of students.

This webinar is part of a series of three webinars on Interdisciplinarity that is presented from November to December 2020 via Microsoft Teams for a duration of 45 minutes each. The webinar topics in the series explore the intersection between Neuroscience and Music, between Science and Entrepreneurship, and between Science and Visual Arts.  

Date: Tuesday 24 November 2020
Topic: The intersection between science and entrepreneurship 
Time: 13:00-13:45 (SAST)
RSVP: Alicia Pienaar, pienaaran1@ufs.ac.za by 23 November 2020 
Platform: Microsoft Teams

Introduction and welcome

Prof Corli Witthuhn 
Vice-Rector: Research at the University of the Free State 


Presenters

Prof Brownhilder Neneh 

Prof Neneh is Associate Professor and Academic Chair (HOD) in the Department of Business Management at the University of the Free State.  She is an NRF-rated researcher in the field of entrepreneurship and small business development. Her research is primarily based in the field of entrepreneurship, where she looks at different aspects of a business venture – from business gestation activities to performance, growth, and exit.  She also focuses on some niche areas in entrepreneurship, such as women and student entrepreneurship. She was a 2019 winner of the Emerald Literati Awards in the category Outstanding and Highly Commended papers. 

Christopher Rothmann – Co-founder of LiquidCulture

Liquid Culture (LC) was started by Christopher Rothmann and Dr Errol Cason in the UFS Department of Microbial, Biochemical and Food Biotechnology in 2018. They produce yeast in its purest liquid form. LC is the only company in Africa to do so. Their yeast is mainly used by breweries for the fermentation of beer and they have since also branched out to the baking and distillery industries. Christopher was awarded the joint runner-up position in the Existing Tech Business category of the 2019 Entrepreneurship Intervarsity.

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept